Literature DB >> 16102824

MEL1S, not MEL1, is overexpressed in myelodysplastic syndromes patients with t(1;3)(p36;q21).

Zhijian Xiao1, Meirong Zhang, Xuping Liu, Yue Zhang, Lin Yang, Yushu Hao.   

Abstract

Balanced chromosomal translocations rarely occur in myelodysplastic syndromes (MDS). We describe here in three further Chinese patients with myelodysplastic syndromes (MDS) whose cytogenetic analysis showed t(1;3)(p36;q21). We detected the expression pattern of MEL1 and MEL1s in BM of two healthy subjects and the three patients, and found that the expression of MEL1s was overexpressed in MDS patients with t(1;3)(p36;q21). Our findings combined previous observations reported in literature support that MDS patients with t(1;3)(p36;q21) should be a new specific subset of MDS. Imbalance of a complete MEL1 message with a PR domain and a short MEL1 message lacking a PR domain (MEL1S) might be involved in the pathogenesis of these patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16102824     DOI: 10.1016/j.leukres.2005.07.002

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  10 in total

1.  PRDM16 Suppresses MLL1r Leukemia via Intrinsic Histone Methyltransferase Activity.

Authors:  Bo Zhou; Jingya Wang; Shirley Y Lee; Jie Xiong; Natarajan Bhanu; Qi Guo; Peilin Ma; Yuqing Sun; Rajesh C Rao; Benjamin A Garcia; Jay L Hess; Yali Dou
Journal:  Mol Cell       Date:  2016-04-14       Impact factor: 17.970

2.  PRDM16 isoforms differentially regulate normal and leukemic hematopoiesis and inflammatory gene signature.

Authors:  David J Corrigan; Larry L Luchsinger; Mariana Justino de Almeida; Linda J Williams; Alexandros Strikoudis; Hans-Willem Snoeck
Journal:  J Clin Invest       Date:  2018-07-23       Impact factor: 14.808

3.  PRDM16s transforms megakaryocyte-erythroid progenitors into myeloid leukemia-initiating cells.

Authors:  Tianyuan Hu; Kiyomi Morita; Matthew C Hill; Yajian Jiang; Ayumi Kitano; Yusuke Saito; Feng Wang; Xizeng Mao; Kevin A Hoegenauer; Kazuhiro Morishita; James F Martin; P Andrew Futreal; Koichi Takahashi; Daisuke Nakada
Journal:  Blood       Date:  2019-07-03       Impact factor: 22.113

4.  Two novel SNPs in the coding region of the bovine PRDM16 gene and its associations with growth traits.

Authors:  J Wang; Z J Li; X Y Lan; L S Hua; Y T Huai; Y Z Huang; L Ma; M Zhao; Y J Jing; H Chen; J Q Wang
Journal:  Mol Biol Rep       Date:  2010-01       Impact factor: 2.316

5.  Downregulation of Prdm16 mRNA is a specific antileukemic mechanism during HOXB4-mediated HSC expansion in vivo.

Authors:  Hui Yu; Geoffrey Neale; Hui Zhang; Han M Lee; Zhijun Ma; Sheng Zhou; Bernard G Forget; Brian P Sorrentino
Journal:  Blood       Date:  2014-07-31       Impact factor: 22.113

6.  Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice.

Authors:  Danielle C Shing; Maurizio Trubia; Francesco Marchesi; Enrico Radaelli; Elena Belloni; Cinzia Tapinassi; Eugenio Scanziani; Cristina Mecucci; Barbara Crescenzi; Idoya Lahortiga; Maria D Odero; Giuseppe Zardo; Alicja Gruszka; Saverio Minucci; Pier Paolo Di Fiore; Pier Giuseppe Pelicci
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

7.  PRDM16 expression in the developing mouse embryo.

Authors:  Kristin H Horn; Dennis R Warner; Michele Pisano; Robert M Greene
Journal:  Acta Histochem       Date:  2009-10-23       Impact factor: 2.479

8.  The zinc finger SET domain gene Prdm14 is overexpressed in lymphoblastic lymphomas with retroviral insertions at Evi32.

Authors:  E J Dettman; Monica J Justice
Journal:  PLoS One       Date:  2008-11-27       Impact factor: 3.240

9.  The methylation profiles of PRDM promoters in non-small cell lung cancer.

Authors:  Shuang-Xiang Tan; Rui-Cheng Hu; Qian Xia; Yong-Li Tan; Jing-Jing Liu; Gui-Xiang Gan; Li-le Wang
Journal:  Onco Targets Ther       Date:  2018-05-22       Impact factor: 4.147

10.  PRDM16 functions as a suppressor of lung adenocarcinoma metastasis.

Authors:  Liang-Ru Fei; Wen-Jing Huang; Yuan Wang; Lei Lei; Zhi-Han Li; Yi-Wen Zheng; Zhao Wang; Mai-Qing Yang; Chen-Chen Liu; Hong-Tao Xu
Journal:  J Exp Clin Cancer Res       Date:  2019-01-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.